Decision Analysis—A Helpful Tool for Clinicians to Establish Diagnostic -Therapeutic Guidelines

References

• Weinstein M C, Fineberg H V. Clinical decision analysis. W.B. Saunders Company, Philadelphia 1980
   Google Scholar
• Cain K C, Greenes R A, Begg C E. Patient-oriented performance measures of diagnostic tests: 3. U-factor. Med Deck Making 1984; 4: 33–46
   PubMedGoogle Scholar
• Greenes R A, Cain K C, Begg C B. Patient-oriented performance measures of diagnostic tests: 1. Tools for prospective evaluation of test order decisions. Med Decis Making 1984; 4: 7–15
   PubMedGoogle Scholar
• Greenes R A, Begg C B, Cain K C, Swets J A, Feehrer C E, McNeil B J. Patient-oriented performance measures of diagnostic tests: 2. Assignment potential and assignment strength. Med Deck Making 1984; 4: 17–31
   PubMedGoogle Scholar
• Glasziou P, Hilden J. Decision tables and logic in decision analysis. Med Decis Making 1986; 6: 154–60
   PubMedGoogle Scholar
• Glasziou P, Hilden J. Threshold analysis of decision tables. Med Deck Making 1986; 6: 161–8
   PubMed Web of Science ®Google Scholar
• Phelps C E, Mushlin A I. Focussing technology assessment using decision theory. Med Deck Making 1988; 8: 279–89
   PubMed Web of Science ®Google Scholar
• Polister P. Decision analysis and clinical judgment. Med Deck Making 1981; 1: 361–89
   PubMedGoogle Scholar
• Dunn V H, Pauker S G. An Ambiguous renal cyst in a patient with prior nephrectomy: What to do when there is only one more to lose. Med Decis Making 1986; 6: 49–62
   PubMedGoogle Scholar
• Eckman M H, Robert N J, Parkinson D R, Latzko G, Pauker S G. Eaton-Lambert syndrome and small cell lung cancer: side effects and certainty. Med Decis Making 1986; 6: 174–86
   PubMedGoogle Scholar
• Fleming C, Wong J B, Moskowitz A J, Pauker S G. A peripar-turn neurologic event: Shooting from the hip. Med Deck Making 1988; 8: 55–71
   PubMedGoogle Scholar
• Plante D A, Piccinllo J F, Sofferman R A. Decision analysis of treatment options in pyriform sinus carcinoma. Med Deck Making 1987; 7: 74–83
   PubMedGoogle Scholar
• Roach P J, Fleming C, Hagen M D, Pauker S G. Prostatic cancer in a patient with asvmotomatic HIV infection. Are some lives more equal than others? Med Decis Making 1988; 8: 132–44
   PubMed Web of Science ®Google Scholar
• Sonnenberg F A, Pauker S G. Elective pericardiectomy for tuberculous pencarditis: should the snappers be snipped? Med Decis Making 1986; 6: 110–23
   PubMedGoogle Scholar
• Tsevat J, Eckman M H, McNutt R A, Pauker S G. Warfin for dilated cardiomyopathy. Med Decis Making 1989; 9: 162–9
   PubMedGoogle Scholar
• Beck J R, Kassirer J P, Pauker S G. A convenient approximation of life expectance. (The DEALE method.) I. Validation of the method. Am J Med 1982; 73: 883–97
   PubMed Web of Science ®Google Scholar
• Beck J R, Pauker S G, Gottleib J E, Klein K, Kassirer J P. A convenient approximation of life expectance. (The DEALE method). II. Used in medical decision making. Am J Med 1982; 73: 889–97
   PubMed Web of Science ®Google Scholar
• Stalpers L JA, van Gasteren H JM, van Daal W AJ. DEALE-ing with life expectancy and mortality rates. Med Deck Making 1989; 9: 150–2
   PubMedGoogle Scholar
• Bagshaw M A. Potential for radiotherapy alone in prostatic cancer. Cancer 1985; 55: 2079–85
   PubMed Web of Science ®Google Scholar
• Byar D P. VACURG studies on prostatic carcinoma and its treatment. Urologic pathology: The prostate, M Tannanbaum. Lee & Febiger, Philadelphia 1977; 241–69
   Google Scholar
• Elder J E, Jewett H J, Walsh P C. Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 1982; 127: 704–6
   PubMed Web of Science ®Google Scholar
• Gibbons R P, Correa R J, Brannen G E, Mason J T. Total prostatectomy for localized prostatic cancer. J Urol 1984; 131: 73–5
   PubMed Web of Science ®Google Scholar
• Grossman H B, Batata M, Hilaris B, Whitmore W F. 125–1 implantation for carcinoma of prostate. Further follow-up of first 100 cases. Urology 1982; 20: 591–8
   PubMed Web of Science ®Google Scholar
• Hanash K A, Utz D C, Cook E N, Taylor W F, Titus J L. Carcinoma of the prostate: a 15-year follow-up. J Urol 1972; 107: 450–3
   PubMed Web of Science ®Google Scholar
• Hilaris B S, Whitemore W F, Batata M, Barzell W E. Behavioral patterns of prostate adenocarcinoma following an 1–125 implant and pelvic node dissection. Int J Radiat Oncol Biol Phys 1977; 2: 631–7
   PubMed Web of Science ®Google Scholar
• Walsh P C, Jewett H J. Radical surgery for prostatic cancer. Cancer 1980; 45: 1906–11
   PubMed Web of Science ®Google Scholar
• Llewellyn-Thomas H, Sutherland H J, Tibshirani R, Ciampi A, Till J E, Boyd H F. The measurement of patients' values in medicine. Med Deck Making 1982; 2: 49–62
   Google Scholar
• Kassirer J R, Pauker S G. The toss-up. N Engl J Med 1981; 305: 1467–9
   PubMedGoogle Scholar
• Beck J R, Pauker S G. The Markov process in medical prognosis. Med Decis Making 1983; 3: 419–57
   PubMed Web of Science ®Google Scholar
• Consensus Conference. The management of clinically localized prostate cancer. JAMA 1987; 258: 2727–30
   PubMedGoogle Scholar
• Consensus Conferences. JAMA 1987; 258: 2738
   PubMedGoogle Scholar
• Freiha F S, Pistenma D A, Bagshaw M A. Pelvic lymphadenec-tomy for staging of prostatic carcinoma: is it always necessary? J Urol 1979; 122: 176–7
   Google Scholar
• Johnson D E, Eschenbach A C. Roles of lymphangiography and pelvic lymphadenectomy in staging prostate cancer. Urology 1981; 17((Suppl))66–71
   PubMedGoogle Scholar
• Loening S A, Schmidt J D, Brown R C, Hawtrey C E, Fallon B, Culp D A. A comparison between lymphangiography and pelvic lymph node dissection in the staging of prostatic cancer. J Urol 1977; 117: 752–5
   PubMed Web of Science ®Google Scholar
• Wajsman Z. Lymph node evaluation in prostatic cancer: is pelvic lymph node dissection necessary?. Urology 1981; 17((Suppl))80–2
   PubMedGoogle Scholar
• Bursztajn H, Hamm R. The clinical utility of utility assessment. Med Deck Making 1982; 2: 161–5
   PubMedGoogle Scholar
• Christensen-Szalanski J J. Discount functions and the measurements of patients values. Womens decisions during childbirth. Med Deck Making 1984; 4: 48–58
   Google Scholar
• Drummond M F. Discussion: Torrance's utility approach to measuring health-related quality of life. J Chron Dis 1987; 40: 601–3
   Google Scholar
• O'Connor A MC, Boyd N F, Trichler D L, Kriukov Y, Sutherland H, Till J E. Eliciting preferences for alternative cancer drug treatments. The influence of framing, medium, and rater variables. Med Deck Making 1985; 5: 454–63
   Google Scholar
• Read J L, Quinn R J, Benvick D M, Fineberg H V, Weinstein M C. Preferences for health outcomes. Comparison of assessment methods. Med Decis Making 1984; 4: 315–29
   PubMed Web of Science ®Google Scholar
• Sackett L, Torrance G W. The utility of different health status as perceived by the general public. J Chron Disease 1978; 31: 697–704
   PubMedGoogle Scholar
• Torrance G W. Utility approach to measuring health-related quality of life. J Chron Dis 1987; 40: 593–600
   PubMedGoogle Scholar
• Cebul R D. A look at the chief complaints revisited: current obstacles and opportunities for decision analysis. Med Decis Making 1984; 4: 271–84
   PubMed Web of Science ®Google Scholar
• Elstein A S, Holzman G B, Ravitch M M, et al. Comparison of physicians' decisions regarding oestrogen replacement therapy model. Am J Med 1986; 80: 246–58
   PubMed Web of Science ®Google Scholar
• Hershey J C, Baron J. Clinical reasoning and cognitive processes. Med Deck Making 1987; 7: 203–11
   PubMed Web of Science ®Google Scholar
• Zwetsloot-Schonk J HM, Pliskin J S, Leer J WH. Analysis of diagnostic-therapeutic strategies in prostate cancer. I: When should a pelvic lymphadenectomy for staging be performed. Theor Surg 1989; 4: 67–78
   Google Scholar
• Zwetsloot-Schonk J HM, Pliskin J S, Leer J WH. Analysis of diagnostic-therapeutic strategies in prostate cancer II: Can lymphography help to select patients for staging lymphadenectomy?. Theor Surg 1989; 4: 147–57
   Google Scholar
• Pauker S G, Kassirer J P. The threshold approach to clinical decision making. N Eng J Med 1980; 302: 1109–17
   PubMed Web of Science ®Google Scholar
• Eisenberg J M, Hershey J C. Derived thresholds. Determining the diagnostic probabilities at which clinicians initiate testing and treatment. Med Decis Making 1983; 3: 155–67
   PubMed Web of Science ®Google Scholar
• Nease R F, Bonduelle Y. Solid recommendations from soft numbers: The test/treatment decision. Med Decis Making 1987; 7: 220–33
   PubMedGoogle Scholar
• Laupacis A, Sackett D L, Roberts R S. An assessment of clinical useful measures of the consequences of treatment. N Engl J Med 1988; 318: 1728–33
   PubMed Web of Science ®Google Scholar
• Brandeau M L, Eddy D M. The work-up of the asymptomatic patient with a positive faecal occult blood test. Med Decis Making 1987; 7: 32–46
   PubMedGoogle Scholar
• Malenka D J, Colice G L, Jacobs C, Beck J R. Mediastinal staging in non-small cell lung cancer. Med Decis Making 1989; 9: 231–42
   PubMedGoogle Scholar
• Haes J CJM, Knippenberg F CE. The quality of life of cancer patients: a review of the literature. Soc Sci Med 1985; 20: 809–17
   PubMed Web of Science ®Google Scholar
• Pauker S G, Kassirer J P. Medical progress, decision analysis. N Engl J Med 1987; 316: 250–8
   PubMed Web of Science ®Google Scholar
• Tversky A, Kahneman D. Judgment under uncertainty: Heuristics and biases. Science 1974; 185: 1124–31
   PubMed Web of Science ®Google Scholar
• McNeil B, Weichselbaum R, Pauker S G. Speech and survival. Trade-offs between qualithy and quantity of life in laryngeal cancer. New Engl J Med 1981; 305: 982–7
   PubMed Web of Science ®Google Scholar
• Pauker S G, McNeil B J. Impact of patient preferences on the selection of therapy. J Chron Dis 1981; 34: 77–86
   PubMedGoogle Scholar
• Kassirer J P, Moskowitz A J, Lau J, Pauker S G. Decision analysis: a progress report. Ann Intern Med 1987; 106: 275–91
   PubMed Web of Science ®Google Scholar
• Critchfield G C, Willard K E. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Deck Making 1986; 6: 85–92
   PubMed Web of Science ®Google Scholar
• Catalona W J, Stein A J. Staging errors in clinically localized prostatic cancer. J Urol 1982; 127: 452–6
   PubMed Web of Science ®Google Scholar
• Fowler J E, Whitmore W F. The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer 1981; 47: 2941–5
   PubMed Web of Science ®Google Scholar
• Lieskovsky G, Skinner D G, Weisenburger T. Pelvic lymphadenectomy in the management of carcinoma of the prostate. J Urol 1980; 124: 635–8
   PubMed Web of Science ®Google Scholar
• Smith J A, Seaman J P, Gleidman J B, Middleton R G. Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and state in 452 consecutive patients. J Urol 1983; 130: 290–2
   PubMed Web of Science ®Google Scholar
• Wilson C S, Dahl D S, Middleton R G. Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer. J Urol 1977; 117: 197–8
   PubMed Web of Science ®Google Scholar
• Brendler C B, Cleeve L K, Anderson E E, Paulson D F. Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit. J Urol 1980; 124: 849–50
   PubMed Web of Science ®Google Scholar
• McCullough D L, McLaughlin A P, Gittes R F. Morbidity of pelvic lymphadenectomy and radical prostatectorny for prostatic cancer. J Urol 1977; 117: 206–7
   PubMed Web of Science ®Google Scholar
• Babcock J R, Grayhack J T. Morbidity of pelvic lymphadenectorny. Urology 1979; 13: 483–6
   PubMed Web of Science ®Google Scholar
• Dewit L, Kian Ang K, Van der Schueren E. Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate. Cancer Treat Rev 1983; 10: 79–89
   PubMedGoogle Scholar
• McLaughlin A P, Saltzstein L, McCullough D L, Gittes R F. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 1976; 115: 89–94
   PubMed Web of Science ®Google Scholar
• Cerny J C, Farah R, Rian R, Weckstein M L. An evaluation of lymphangiography in staging carcinoma of the prostate. J Urol 1975; 113: 367–70
   PubMedGoogle Scholar
• Paulson D F, Piserchia P V, Gardner W. Predictors of lymphatic spread in prostatic adenocarcinoma: Uro-Oncology research Group Study. J Urol 1980; 123: 697–9
   PubMedGoogle Scholar
• Spellman M C, Castellino R A, Ray G R, Pistenma D A, Bagshaw M A. An evaluation of lymphangiography in localized carcinoma of the prostate. Radiology 1977; 125: 637–44
   PubMed Web of Science ®Google Scholar